| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 277.45B | 278.80B | 251.14B | 207.06B | 212.11B |
| Gross Profit | 60.01B | 60.33B | 63.16B | 56.44B | 20.74B |
| EBITDA | 56.47B | 62.71B | 69.33B | 58.38B | 62.90B |
| Net Income | 24.76B | 25.58B | 31.37B | 28.09B | 32.40B |
Balance Sheet | |||||
| Total Assets | 1.08T | 1.13T | 1.19T | 1.08T | 949.80B |
| Cash, Cash Equivalents and Short-Term Investments | 122.68B | 137.03B | 119.73B | 96.61B | 108.01B |
| Total Debt | 287.72B | 266.29B | 239.33B | 224.22B | 185.78B |
| Total Liabilities | 659.67B | 731.65B | 807.03B | 739.62B | 657.73B |
| Stockholders Equity | 289.61B | 272.51B | 264.87B | 244.05B | 226.53B |
Cash Flow | |||||
| Free Cash Flow | 37.89B | 45.62B | 46.09B | -6.07B | 59.32M |
| Operating Cash Flow | 38.79B | 46.59B | 47.35B | -4.14B | 2.25B |
| Investing Cash Flow | -51.31B | -22.42B | -39.30B | -39.34B | -27.80B |
| Financing Cash Flow | -3.01B | -5.69B | 8.97B | 26.14B | 40.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$396.13B | 6.70 | 3.55% | 3.89% | 4.66% | 26.27% | |
74 Outperform | HK$176.04B | 7.34 | 2.75% | 4.33% | 27.01% | -20.16% | |
73 Outperform | HK$256.14B | 3.64 | 8.80% | 5.18% | 1.05% | -0.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
58 Neutral | HK$174.24B | 10.85 | 3.54% | 4.54% | -9.39% | -19.08% | |
58 Neutral | HK$59.11B | -6.27 | 0.65% | 3.96% | -23.93% | -90.51% | |
41 Neutral | HK$47.69B | -1.28 | -59.37% | ― | -28.73% | -60.86% |